This trial is testing if it is safe to give three different schedules of radiation therapy to the pelvis and prostate to see if it kills cancer cells while not harming normal cells too much.
- Prostate Cancer
- Prostate Adenocarcinoma
1 Primary · 5 Secondary · Reporting Duration: 1 month after completion of treatment, every 3 months for year 1, and every 6 months during Year 2
3 Treatment Groups
Dose Level 3
1 of 3
Dose Level 1
1 of 3
Dose Level 2
1 of 3
18 Total Participants · 3 Treatment Groups
Primary Treatment: Hypofractionated Radiation Therapy · No Placebo Group · Phase 1
Who is running the clinical trial?
Age 18+ · Male Participants · 11 Total Inclusion CriteriaMark “Yes” if the following statements are true for you:
Frequently Asked Questions
To what magnitude is the current participant pool of this trial?
"Affirmative, clinicaltrials.gov records indicate that this trial has been actively recruiting since November 19th 2020 and is currently in search of 18 patients to be enrolled at 1 medical centre." - Anonymous Online Contributor
Is Hypofractionated Radiation Therapy a reliable approach for ensuring safety?
"As this is an initial stage trial, the safety of Hypofractionated Radiation Therapy was scored a 1 due to limited clinical data indicating its efficacy and safety." - Anonymous Online Contributor
Is the recruitment process for this research endeavor still ongoing?
"Per clinicaltrials.gov, the researchers are actively seeking participants for this experiment, which was posted on November 19th 2020 and most recently updated April 26th 2022." - Anonymous Online Contributor